Market Research Hub

Global Autoimmune Treatment Industry Outlook and Detailed Forecast on Market Revenues During 2017-2021


Albany, NY -- (SBWIRE) -- 10/12/2017 -- The prevalence of autoimmune disease is on the rise. According to National Institute of Health, nearly 50 million of Americans suffer from autoimmune diseases. This rising incidence of autoimmune diseases across the globe has fortified the drug manufacturers and research companies to introduce effective drugs and treatments, consequently boosting the autoimmune treatment market. A new study, titled "Global Autoimmune Treatment Industry 2017, Trends and Forecast Report" has been recently broadcasted to the vast repository of Market Research Hub (MRH), which offers a precise outlook on the current market scenario along with future growth prospects. It also explains the competitive landscape present in the market along with detailed profile of the leading companies.

Request Free Sample Report:

Autoimmune disease is a condition where the body's immune system considers its own body tissues and organs as foreign and attacks them. Some of the common types of autoimmune diseases are inflammatory bowel disease, Crohn's disease, multiple sclerosis, rheumatoid arthritis, systemic lupus erythematosus. The diseases are estimated to be one of the top 10 cause of death in women under the age 65 and is the second highest cause of chronic illness. It has been analyzed that autoimmune conditions cannot be prevented or cured as the cause of such conditions is still unknown. Presently, treatment for autoimmune diseases depends on types of disease. Treatment for autoimmune diseases includes blood transfusion, supplements, drugs and physical therapy.

At first, the report begins with a brief summary along with a market snapshot providing information of the various segments and sub-segments considered in the scope of the study. For a better understanding of the global market for autoimmune treatment, the analysts have broadcasted the market into Europe, North America and Asia Pacific. Whereas, the main countries covered in this report are China, Japan, South Korea, Germany, United Kingdom and the United States. Also, the report gives a detailed overview of the key drivers, restraints and trends in the market that are estimated to have a major influence on the present and future development of the market.

As per the study key highlights, due to the growing public awareness and increasing automation of laboratories, autoimmune treatment market has showcased significant growth in terms of revenue in 2017. With technological advancements in the healthcare industry, the global market for autoimmune treatment is anticipated to witness progressive CAGR and substantial revenue throughout the forecast period of 2017 to 2021.

Browse Full Report with TOC-

The next section talks about the market segmentation which includes segregation on the basis of product categories, applications and end-users. On the basis of product type, the study covers Rheumatoid arthritis, Type 1 diabetes and Inflammatory bowel disease. Major end-users are Hospitals, Independent Laboratories, Physician Practices. For each segment, the study provides information on sales volume, revenue (Million USD), product price, market share and growth rate.

As the report concludes, readers are offered information about the competitive landscape, which details about the various players active in the global market. They are Bristol-Myers Squibb Company, Haoeyou, Abott, GlaxoSmithKline, Astellas Pharma and Novartis AG.

Enquire about this Report-

About Market Research Hub
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH's expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us
90 State Street,
Albany, NY 12207,
United States
Toll Free : 800-998-4852 (US-Canada)
Email :
Website :
Read Industry News at -